These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 35448854)

  • 1. The Microbiome and Uremic Solutes.
    Zaidan N; Nazzal L
    Toxins (Basel); 2022 Mar; 14(4):. PubMed ID: 35448854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Renal Clinician's Guide to the Gut Microbiota.
    Snelson M; Biruete A; McFarlane C; Campbell K
    J Ren Nutr; 2020 Sep; 30(5):384-395. PubMed ID: 31928802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the Composition of Gut Microbiota Affect Chronic Kidney Disease? Molecular Mechanisms Contributed to Decreasing Glomerular Filtration Rate.
    Młynarska E; Budny E; Saar M; Wojtanowska E; Jankowska J; Marciszuk S; Mazur M; Rysz J; Franczyk B
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota issue in CKD: how promising are gut-targeted approaches?
    Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
    J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components.
    Ondrussek-Sekac M; Navas-Carrillo D; Orenes-Piñero E
    Crit Rev Food Sci Nutr; 2021; 61(9):1490-1502. PubMed ID: 32393049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Gut Microbiota in Kidney Disease: The Future in Renal Nutrition and Metabolism.
    Lambert K; Rinninella E; Biruete A; Sumida K; Stanford J; Raoul P; Mele MC; Wang AY; Mafra D
    J Ren Nutr; 2023 Nov; 33(6S):S30-S39. PubMed ID: 37632511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota and Cardiovascular Uremic Toxicities.
    Velasquez MT; Centron P; Barrows I; Dwivedi R; Raj DS
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29997362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotics (Pre-, Pro-, Post-) and Uremic Toxicity: Implications, Mechanisms, and Possible Therapies.
    Mitrea L; Medeleanu M; Pop CR; Rotar AM; Vodnar DC
    Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease.
    Mafra D; Borges N; Alvarenga L; Esgalhado M; Cardozo L; Lindholm B; Stenvinkel P
    Nutrients; 2019 Feb; 11(3):. PubMed ID: 30818761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota and prebiotics modulation of uremic toxin generation.
    Koppe L; Fouque D
    Panminerva Med; 2017 Jun; 59(2):173-187. PubMed ID: 28001024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Kidney Injury and Gut Dysbiosis: A Narrative Review Focus on Pathophysiology and Treatment.
    Chou YT; Kan WC; Shiao CC
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the Importance of Biotics in Gut Barrier Integrity.
    Kocot AM; Jarocka-Cyrta E; Drabińska N
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota as a Source of Uremic Toxins.
    Popkov VA; Zharikova AA; Demchenko EA; Andrianova NV; Zorov DB; Plotnikov EY
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal Microbiota Transplantation in Reducing Uremic Toxins Accumulation in Kidney Disease: Current Understanding and Future Perspectives.
    Caggiano G; Stasi A; Franzin R; Fiorentino M; Cimmarusti MT; Deleonardis A; Palieri R; Pontrelli P; Gesualdo L
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
    da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
    Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.
    Vitetta L; Linnane AW; Gobe GC
    Toxins (Basel); 2013 Nov; 5(11):2042-57. PubMed ID: 24212182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.